LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer

Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma

(2019) Zhikui Liu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Prediction of Recurrence in Cervical Cancer Using a Nine-lncRNA Signature

(2019) Yu Mao et al.   Frontiers in Genetics

The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy

(2019) Ji Wang et al.   Journal of Hematology & Oncology

MiR-16-5p inhibits breast cancer by reducing AKT3 to restrain NF-κB pathway

(2019) Liwei Ruan et al.   BIOSCIENCE REPORTS

Exosomal miR-16-5p as a target for malignant mesothelioma

(2019) Phillip B. Munson et al.   Scientific Reports

Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer

(2018) Juan Gu et al.   CANCER LETTERS

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance Tamoxifen resistance in breast cancer

(2018) Yun Ma et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Vasodilator-Stimulated Phosphoprotein (VASP) depletion from breast cancer MDA-MB-231 cells inhibits tumor spheroid invasion through downregulation of Migfilin, β-catenin and urokinase-plasminogen activator (uPA)

(2017) Vasiliki Gkretsi et al.   EXPERIMENTAL CELL RESEARCH

miR-613 inhibits proliferation and invasion of breast cancer cell via VEGFA

(2016) Junzhao Wu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

miR-15a/miR-16 induces mitochondrial dependent apoptosis in breast cancer cells by suppressing oncogene BMI1

(2016) Nibedita Patel et al.   LIFE SCIENCES

Competing endogenous RNA networks of CYP4Z1 and pseudogene CYP4Z2P confer tamoxifen resistance in breast cancer

(2016) Lufeng Zheng et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells

(2016) S Bhatt et al.   ONCOGENE

The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression

(2016) Yashar S. Niknafs et al.   Nature Communications

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

(2015) Jack Cuzick et al.   LANCET ONCOLOGY

The emerging role of lncRNAs in cancer

(2015) Maite Huarte   NATURE MEDICINE

LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer

(2015) X Xue et al.   ONCOGENE

Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells

(2015) Yehua Shen et al.   TUMOR BIOLOGY

MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ*

(2015) Mingrong Lü et al.   Scientific Reports

Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer

(2015) Jingpu Zhang et al.   Theranostics

MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells

(2014) J Cui et al.   ONCOGENE

Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer

(2012) Xiaoyan Chen et al.   PATHOLOGY RESEARCH AND PRACTICE

Autophagy: assays and artifacts

(2010) Sandra Barth et al.   JOURNAL OF PATHOLOGY

Mammalian microRNAs predominantly act to decrease target mRNA levels

(2010) Huili Guo et al.   NATURE

Green tea (−)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity

(2009) Yimin Zhang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY